Grandfield & Dodd’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Grandfield & Dodd's AZN Position: Q3 2026 in Review
Grandfield & Dodd increased its AstraZeneca (AZN) stake by 1.4% in Q3 2026, buying an estimated $7K and bringing the position to 2,977 shares worth $481K. The position accounts for 0.03% of the portfolio, ranked #152.
Grandfield & Dodd first reported a position in AZN in Q3 2021 and has held it in 21 quarters since. The position peaked at $870K in Q2 2022. 1,438 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Grandfield & Dodd held 2,977 shares of AstraZeneca worth $481K as of Q3 2026.
- Grandfield & Dodd bought 42 AstraZeneca shares in Q3 2026, an estimated $7K.
- AstraZeneca made up 0.03% of Grandfield & Dodd's portfolio in Q3 2026, its #152 holding.
- Grandfield & Dodd first reported a position in AstraZeneca in Q3 2021 and has held it in 21 quarters since.
- Grandfield & Dodd's AstraZeneca position peaked at $870K in Q2 2022.
- 1,438 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Grandfield & Dodd's 13F filing for Q3 2026, filed 29 Oct 2026.